



























2‐amine	 (2a),	 (N‐(3,4‐dimethoxyphenyl)methylene]‐1H‐benzimidazol‐2‐amine	 (2b),	 and	 (N‐
(3,4,5‐trimethoxyphenyl)methylene]‐1H‐benzimidazol‐2‐amine	 (2c)	 were	 synthesized	 by
reaction	of	a	Schiff	base	with	malononitrile	in	absolute	ethanol.	Structures	of	compounds	have
been	 confirmed	 by	 IR,	 1H	NMR	 and	 elemental	 analysis.	 Compounds	 2a‐c	were	 screened	 for













Cancer	 is	 the	 biggest	 health	 issue	 in	 the	 world.	 Cancer	
developed	 resistance	 against	 many	 existing	 anticancer	 drugs.	
This	 keeps	 a	 research	 window	 open	 in	 search	 for	 newer	
anticancer	molecules.	However,	it	is	rather	difficult	to	come	up	
with	a	molecule	that	can	selectively	inhibit	the	proliferation	of	
abnormal	 cells	 only	 with	 least	 or	 no	 effect	 on	 normal	 cells.	





reported	 to	 exhibit	 antitumor	 [6],	 antibacterial	 [7],	 anti‐
inflammatory	 [8]	 and	 promising	 anticancer	 activities	 [9‐10].	
Moreover,	 benzimidazoles	 have	 been	 used	 as	 biomimetic	 of	
guanine	 residues	 [11]	 and	 they	 selectivity	 inhibit	 endothelial	
cell	growth	and	suppress	angiogenesis	in	vivo	and	in	vitro	[12].	
Due	 to	 a	 broad	 spectrum	 of	 activities	 noted	 so	 far	 and	 in	










dine	 and	 malononitrile	 were	 obtained	 commercially	 from	
Aldrich	and	Fluka	Chemicals.	Solvents	were	reagent	grade	and	
were	used	as	received:	dry	absolute	ethanol,	petroleum	ether,	
n‐hexane	 and	 ethyl	 acetate.	 Progress	 of	 reactions	 was	
monitored	 by	 thin	 layer	 chromatography	 (TLC)	 using	





Melting	 points	 were	 measured	 on	 an	 electrothermal	
melting	 point	 apparatus	 and	 were	 not	 corrected.	 Fourier‐
transform	 infrared	 spectra	 were	 recorded	 using	 the	 KBr	 disc	
technique	on	a	JASCO	410	FTIR	spectrophotometer.	Elemental	
(CHN)	 analysis	 was	 performed	 using	 an	 Exeter	 CE‐440	
elemental	 analyzer.	 1H	 NMR	 spectra	 of	 the	 compounds	 were	
recorded	 on	 a	 Varian	 Gemini‐200	 spectrometer	 (200	 MHz)	
using	 DMSO‐d6	 as	 solvent	 and	 TMS	 as	 internal	 reference.	
Anticancer	 activity	 was	 evaluated	 at	 the	 International	 Center	






through	 the	 method	 described	 by	 Nawrocka	 et	 al.	 [13]	
involving	 the	 condensation	 of	 an	 equimolar	 mixture	 of	 2‐
aminobenzimidazole	 (0.01	 mol)	 and	 the	 aldehyde	 as	 3,4,5‐
trimethoxybenzaldehyde	 (0.01	 mol),	 3,4‐dimethoxybenz‐
aldehyde	 (0.01	mol)	 and	 4‐methoxybenzaldehyde	 (0.01	mol),	
respectively,	 in	ethanol	(25	mL).	The	mixture	was	refluxed	for	





Schiff	 base	 compounds	 (0.01	 mol)	 were	 reacted	 with	
malanonitrile	(0.01	mol)	 in	ethanol	with	a	catalytic	amount	of	
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Then	 the	 reaction	mixture	 was	 poured	 onto	 crushed	 ice	 and	
neutralized	by	hydrochloric	acid	to	give	a	crude	product	which	
was	 filtered	 off,	 washed	 several	 times	with	 cold	 water,	 dried	
and	crystallized	(Scheme	1).	
4‐Amino‐2‐(4‐methoxyphynyl)benzo[4,5]imidazo[1,2‐a]	
pyrimidine‐3‐carbonitrile	 (2a):	 Yellow	 crystals,	 recrystallized	
from	ethanol.	Yield:	35%.	M.p.:	103‐105	oC.	FT‐IR	(KBr,	,	cm‐1):	
3367	 (NH2)	 (amine),	 2222	 (CN)	 (cyano),	 1645,	 1605	 (C=N)	
(pyrimidine	 and	 imidazole),	 1571	 (C=C)	 (aromatic).	 1H	 NMR	
(200	MHz,	DMSO	d6,	δ,	ppm):	3.90	(s,	3H,	OCH3,),	6.90‐8.40	(m,	
8H,	 Ar‐H,	 NH2).	 Anal.	 calcd.	 for	 C18H13N5O:	 C,	 68.6;	 H,	 4.2;	 N,	
22.2.	Found:	C,	68.9;	H,	3.9;	N,	21.9%.	
4‐Amino‐2‐(3,4‐dimethoxyphenyl)benzo[4,5]imidazo[1,2‐a]	
pyrimidine‐3‐carbonitrile	 (2b):	 Dark	 Yellow	 crystals,	
recrystallized	from	ethanol.	Yield:	30%.	M.p.:	143‐144	oC.	FT‐IR	
(KBr,	,	 cm‐1):	 3372	 (NH2)	 (amine),	 2222	 (CN)	 (cyano),	 1642,	
1600	 (C=N)	 (pyrimidine	 and	 imidazole),	 1581	 (C=C)	
(aromatic).	 1H	NMR	(200	MHz,	DMSO	d6,	 δ,	ppm):	3.80	(s,	3H,	







1600	 (C=N)	 (pyrimidine	 and	 imidazole),	 1582	 (C=C)	
(aromatic).	1H	NMR	(200	MHz,	DMSO‐	d6,	δ,	ppm):	3.99	(s,	6H,	






Cytotoxic	 activity	 of	 compounds	was	 evaluated	 in	 96‐well	
flat‐bottomed	microplates	by	using	 the	standard	MTT	 (3‐[4,5‐
dimethylthiazole‐2‐yl]‐2,5‐diphenyl‐tetrazolium	 bromide)	
colorimetric	 assay	 [14].	 For	 this	 purpose,	 PC‐3	 cells	 (Prostate	
Cancer)	 and	 HeLa	 cells	 were	 cultured	 in	 Dulbecco’s	 Modified	
Eagle’s	 Medium,	 and	 Minimal	 Essential	 Medium	 (MEM),	
supplemented	with	5%	of	fetal	bovine	serum	(FBS),	100	IU/mL	
of	 penicillin	 and	 100	 µg/mL	 of	 streptomycin	 in	 25	 cm3	 flask,	
and	kept	 in	5%	CO2	 incubator	at	37	oC.	Exponentially	growing	
cells	 were	 harvested,	 counted	 with	 haemocytometer	 and	
diluted	 with	 a	 particular	 medium.	 Cell	 culture	 with	 the	
concentration	of	1x105	cells/mL	was	prepared	and	introduced	
(100	 µL/well)	 into	 96‐well	 plates.	 After	 overnight	 incubation,	
medium	was	removed	and	200	µL	of	fresh	medium	was	added	
with	different	concentrations	of	compounds	(1‐100	µM).	After	
48	 h,	 50	 µL	 MTT	 (2	 mg/mL)	 was	 added	 to	 each	 well	 and	
incubated	 further	 for	 4	hours.	 Subsequently,	 100	µL	of	DMSO	
was	 added	 to	 each	 well.	 The	 extent	 of	 MTT	 reduction	 to	
formazan	 within	 cells	 was	 calculated	 by	 measuring	 the	
absorbance	at	570	nm,	using	a	micro	plate	reader	(Spectra	Max	
plus,	 Molecular	 Devices,	 Ca,	 USA).	 The	 cytotoxicity	 was	















IR	 spectra	 of	 compounds	 2a‐c	 showed	 absorption	 bands	
characteristic	 for	NH2	at	3367,	3372	and	3397	cm‐1	and	CN	at	






Results	 of	 in	 vitro	 anticancer	 activity	 of	 the	 tested	
compounds	 2a‐c	 were	 evaluated	 for	 cytotoxicity	 against	 PC3	
cells	and	Hela	cells	of	humans	in	comparison	with	doxorubicin	
as	 a	 positive	 control.	 All	 tested	 compounds	 showed	 a	 limited	
cytotoxic	 activity	 except	 compound	2a	 that	 showed	moderate	
cytotoxic	 effect	 towards	 Hela	 cells.	 Table	 1	 represents	 the	
cytotoxic	activity	of	the	tested	compounds.		
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The	 present	 work	 describes	 the	 synthesis	 and	 in	 vitro	
anticancer	evaluation	of	some	cyclic	benzimidazole	derivatives	

























[10]. Huang,	 S.	 T.;	 Hsei,	 I.	 J.;	 Chen,	 C.	Bioorg.	Med.	Chem.	2006,	14,	 6106‐
6119.		
[11]. Boiani,	M.;	Gonzalez,	M.	Mini‐Rev.	Med.	Chem.	2005,	5,	409‐424.		
[12]. Hori,	A.;	Imaeda,	Y.;	Kubo,	K.;	Kusaka,	M.	Cancer	lett.	2002,	183,	53‐62.		
[13]. Nawrocka,	W;	Sztuba,	B.;	Kowalska,	M.	W.;	Liszkiewicz,	H.;	Wietrzyk,	
J.;	Nasulewicz,	A.;	Pelczynska,	M.;	Opolski,	A.	Il	Farmaco	2004,	59(2),	
83‐91.		
[14]. Mosmann,	T.	J.	Immunol.	Methods	1983,	65(1‐2),	55‐63.		
	
	
	
